The DOI matches its Crossref record; 426 of the 426 references it cites were found in a registry or an index.
The essential elements of Alzheimer’s disease
Open accessAbstract
Treatments for Alzheimer's disease (AD) directed against the prominent amyloid plaque neuropathology are yet to be proved effective despite many phase 3 clinical trials. There are several other neurochemical abnormalities that occur in the AD brain that warrant renewed emphasis as potential therapeutic targets for this disease. Among those are the elementomic signatures of iron, copper, zinc, and selenium. Here, we review these essential elements of AD for their broad potential to contribute to Alzheimer's pathophysiology, and we also highlight more recent attempts to translate these findings into therapeutics. A reinspection of large bodies of discovery in the AD field, such as this, may inspire new thinking about pathogenesis and therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–426 of 426
Zhao, J. J., Gao, W., Yang, Z., Li, H., & Gao, Z. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.10.005 · Cited by 25
Datki, Z., Galik-Olah, Z., Mózes, E., Szegedi, V., Kálmán, J., Hunya, Á. G., Fülöp, L., Tamano, H., Takeda, A., Adlard, P. A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0800-y · Cited by 25
Self-citationIsolation of a phosphorylated soluble Tau fraction from Alzheimer's disease brain
Ledesma, M. D., Avila, J., & Correas, I. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00075-p · Cited by 24
Iron is a specific cofactor for distinct oxidation- and aggregation-dependent Aβ toxicity mechanisms
Ott, S., Dziadulewicz, N., & Crowther, D. C. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019042 · Cited by 24
Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain
Lee, J., Cho, E., Kim, T.-Y., Kim, D., Palmiter, R. D., Volitakis, I., Kim, J. S., Bush, A. I., & Koh, J. (2010) · BioMetals · doi:10.1007/s10534-010-9354-9 · Cited by 23
Self-citationUnblinded by the light: amyloid‐related imaging abnormalities in Alzheimer’s clinical trials
Gleason, A. J., Ayton, S., & Bush, A. I. (2020) · European Journal of Neurology · doi:10.1111/ene.14484 · Cited by 23
Self-citationvan der Weerd, L., Lefering, A. J. E., WEBB, A. G., Egli, R., & Bossoni, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-73324-5 · Cited by 23
Zinc affects the proteolytic stability of Apolipoprotein E in an isoform-dependent way
Xu, H. J., Gupta, V. B., Martins, I. J., Martins, R. N., Fowler, C. J., Bush, A. I., Finkelstein, D. I., & Adlard, P. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.016 · Cited by 21
Self-citationGuerreiro, C. C., Silva, B. D. R., Crespo, Â. C., Marques, L., Costa, S., Timóteo, Â., Marcelino, E., Maruta, C., Vilares, A., Matos, M., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.07.017 · Cited by 19
4-Hydroxynonenal disrupts zinc export in primary rat cortical cells
SMITH, J., Xiong, S., & Lovell, M. A. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.05.009 · Cited by 19
Yao, D., Jing, T., Niu, L., Huang, X.-X., Wang, Y., Deng, X., & Wang, M. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.09.003 · Cited by 19
Maynard, C. J., Cappai, R., Volitakis, I., Laughton, K. M., Masters, C. L., Bush, A. I., & Li, Q. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9401-7 · Cited by 18
Self-citationLeong, S. L., Young, T. R., Barnham, K. J., Wedd, A. G., Hinds, M. G., Xiao, Z., & Cappai, R. (2013) · Metallomics · doi:10.1039/c3mt00258f · Cited by 17
Ichinohe, N., Hayashi, M., Wakabayashi, K., & Rockland, K. S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.063 · Cited by 15
Girvan, P., Miyake, T., Teng, X., Branch, T., & Ying, L. (2016) · ChemBioChem · doi:10.1002/cbic.201600255 · Cited by 14
Zou, Z., Cai, J., Zhong, A., Zhou, Y., Wang, Z., Wu, Z., Yang, Y. J., Li, X., Cheng, X., Tan, J., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.11.014 · Cited by 14
Diagnostics and Treatments of Iron-Related CNS Diseases
Xiong, H., Tuo, Q., Guo, Y., & Lei, P. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_10 · Cited by 14
Self-citationContribution of iron and Aβ to age differences in entorhinal and hippocampal subfield volume
Foster, C. M., Kennedy, K. M., Daugherty, A. M., & Rodrigue, K. M. (2020) · Neurology · doi:10.1212/wnl.0000000000010868 · Cited by 13
Kim, D., Bang, J. K., & Kim, S. H. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201410389 · Cited by 12
Rapid Generation of Dityrosine Cross-linked Aβ Oligomers via Cu-Redox Cycling
Gunn, A. P., Roberts, B. R., & Bush, A. I. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-551-0_1 · Cited by 11
Self-citationAxonal dispatch of iron in neuronal signaling
Lei, P., Ayton, S., & Bush, A. I. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0394-3 · Cited by 10
Self-citationMolecular modeling of the inhibitory mechanism of copper(II) on aggregation of amyloid β-peptide
Jiao, Y. (2005) · Science China Chemistry · doi:10.1360/042004-93 · Cited by 9
Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
Craddock, T. J. A., Tuszyński, J. A., Chopra, D., Casey, N. F., Goldstein, L. E., Hameroff, S. R., & Tanzi, R. E. (2012) · PLoS ONE · doi:10.1371/annotation/866da844-12ad-4fef-a57e-92a4549e035c · Cited by 8
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
The involvement of dityrosine crosslinks in lipofuscin accumulation in Alzheimer’s disease
Al‐Hilaly, Y. K., Mohammed, A. H., Thorpe, J. R., & Serpell, L. C. (2019) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1294/6/062107 · Cited by 6
Decreasing iron neurotoxicity in pantothenate kinase-associated neurodegeneration
Ayton, S., & Bush, A. I. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30193-0 · Cited by 3
Self-citation
Cited by
Copper homeostasis and cuproptosis in health and disease
Chen, L., Min, J., & Wang, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01229-y · Cited by 1,493
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications
Tuo, Q., Zhang, S., & Lei, P. (2022) · Medicinal Research Reviews · doi:10.1002/med.21817 · Cited by 728
Self-citationTherapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
Pardo-Moreno, T., González-Acedo, A., Rivas-Domínguez, A., García-Morales, V., García-Cozar, F. J., Ramos-Rodríguez, J. J., & Melguizo-Rodríguez, L. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061117 · Cited by 239
The mechanisms of ferroptosis and its role in alzheimer’s disease
Ma, H., Dong, Y., Chu, Y., Guo, Y., & Li, L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.965064 · Cited by 115
Zinc and Central Nervous System Disorders
Wang, B., Fang, T., & Chen, H. (2023) · Nutrients · doi:10.3390/nu15092140 · Cited by 93
Metadata
- Authors
- Lei, P., Ayton, S., & Bush, A. I.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 296
- Pages
- 100105
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W3098335778
- Cited by
- 327
- References
- 426
- FWCI
- 18.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.